Total Payments
$11,169
2024 Payments
$53.47
Companies
17
Transactions
55
Medicare Patients
5,134
Medicare Billing
$2.5M
Payment Breakdown by Category
Other$5,150 (46.1%)
Consulting$2,142 (19.2%)
Travel$2,052 (18.4%)
Food & Beverage$1,801 (16.1%)
Education$23.93 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Honoraria | $5,150 | 3 | 46.1% |
| Consulting Fee | $2,142 | 3 | 19.2% |
| Travel and Lodging | $2,052 | 7 | 18.4% |
| Food and Beverage | $1,801 | 41 | 16.1% |
| Education | $23.93 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novocure Inc. | $9,181 | 26 | $0 (2023) |
| GENZYME CORPORATION | $1,149 | 2 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $193.34 | 7 | $0 (2024) |
| Blue Earth Diagnostics Limited | $124.99 | 1 | $0 (2023) |
| Sunovion Pharmaceuticals Inc. | $113.34 | 1 | $0 (2017) |
| INSYS Therapeutics Inc | $83.74 | 5 | $0 (2018) |
| GE HealthCare | $76.22 | 2 | $0 (2022) |
| Myovant Sciences Inc. | $47.06 | 2 | $0 (2022) |
| Varian Medical Systems, Inc. | $36.22 | 1 | $0 (2019) |
| Olympus America Inc. | $25.95 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $53.47 | 3 | AstraZeneca Pharmaceuticals LP ($28.12) |
| 2023 | $417.25 | 5 | Novocure Inc. ($153.06) |
| 2022 | $233.25 | 4 | Novocure Inc. ($142.78) |
| 2021 | $47.13 | 2 | Myovant Sciences Inc. ($23.93) |
| 2020 | $24.91 | 1 | Novocure Inc. ($24.91) |
| 2019 | $1,318 | 10 | GENZYME CORPORATION ($1,149) |
| 2018 | $240.99 | 8 | Novocure Inc. ($138.21) |
| 2017 | $8,835 | 22 | Novocure Inc. ($8,684) |
All Payment Transactions
55 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $13.99 | General |
| 09/26/2024 | Becton, Dickinson and Company | PowerPort M.R.I. Implantable Port (Device) | Food and Beverage | In-kind items and services | $25.35 | General |
| Category: Vascular/Oncology | ||||||
| 05/09/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $14.13 | General |
| 12/20/2023 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $19.30 | General |
| 12/01/2023 | Novocure Inc. | — | Food and Beverage | Cash or cash equivalent | $153.06 | General |
| 11/30/2023 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $100.08 | General |
| Category: Oncology | ||||||
| 10/19/2023 | Blue Earth Diagnostics Limited | POSLUMA (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Diagnostic Imaging | ||||||
| 01/19/2023 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: HORMONE THERAPY | ||||||
| 05/27/2022 | Bayer HealthCare Pharmaceuticals Inc. | Xofigo (Drug), Nubeqa | Food and Beverage | In-kind items and services | $23.47 | General |
| Category: Oncology | ||||||
| 05/26/2022 | Myovant Sciences Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $23.13 | General |
| Category: HORMONE THERAPY | ||||||
| 05/10/2022 | GE HealthCare | — | Food and Beverage | Cash or cash equivalent | $43.87 | General |
| 05/05/2022 | Novocure Inc. | Optune (Device) | Food and Beverage | Cash or cash equivalent | $142.78 | General |
| Category: Oncology | ||||||
| 09/27/2021 | Myovant Sciences Inc. | ORGOVYX (Drug) | Education | In-kind items and services | $23.93 | General |
| Category: HORMONE THERAPY | ||||||
| 02/01/2021 | Curium US LLC | Detectnet (Drug) | Food and Beverage | In-kind items and services | $23.20 | General |
| Category: Radioactive diagnostic agent | ||||||
| 01/27/2020 | Novocure Inc. | Oncology (Device) | Food and Beverage | Cash or cash equivalent | $24.91 | General |
| Category: Optune Lua | ||||||
| 11/14/2019 | AstraZeneca Pharmaceuticals LP | IMFINZI (Drug) | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: Oncology | ||||||
| 11/07/2019 | GENZYME CORPORATION | LIBTAYO (Drug) | Consulting Fee | Cash or cash equivalent | $1,142.00 | General |
| Category: ONCOLOGY | ||||||
| 09/30/2019 | Novocure Inc. | Oncology (Device) | Food and Beverage | Cash or cash equivalent | $17.05 | General |
| Category: Optune | ||||||
| 09/23/2019 | Novocure Inc. | Oncology (Device) | Food and Beverage | Cash or cash equivalent | $21.66 | General |
| Category: Optune | ||||||
| 08/31/2019 | Smith+Nephew, Inc. | Santyl (Drug) | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: Pharma Product | ||||||
| 08/08/2019 | AstraZeneca Pharmaceuticals LP | IMFINZI (Drug) | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: Oncology | ||||||
| 06/26/2019 | GENZYME CORPORATION | JEVTANA (Drug) | Food and Beverage | In-kind items and services | $7.18 | General |
| Category: ONCOLOGY | ||||||
| 03/14/2019 | Varian Medical Systems, Inc. | TrueBeam (Device) | Food and Beverage | In-kind items and services | $36.22 | General |
| Category: Devices | ||||||
| 03/14/2019 | AstraZeneca Pharmaceuticals LP | IMFINZI (Drug) | Food and Beverage | In-kind items and services | $17.46 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/07/2019 | GE HEALTHCARE | — | Food and Beverage | Cash or cash equivalent | $32.35 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 1,103 | 3,807 | $4.2M | $548,450 |
| 2022 | 26 | 1,218 | 4,326 | $4.4M | $618,508 |
| 2021 | 29 | 1,368 | 4,712 | $4.5M | $701,684 |
| 2020 | 30 | 1,445 | 4,773 | $3.9M | $606,588 |
Total Patients
5,134
Total Services
17,618
Medicare Billing
$2.5M
Procedure Codes
159
All Medicare Procedures & Services
159 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G6015 | Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | Office | 2023 | 104 | 760 | $2.1M | $219,357 | 10.4% |
| 77014 | Ct guidance for insertion of radiation therapy fields | Office | 2023 | 83 | 564 | $345,732 | $54,781 | 15.8% |
| 77373 | Cranial lesion surgery using radiation over multiple sessions | Office | 2023 | 18 | 47 | $385,870 | $38,098 | 9.9% |
| 77427 | Radiation treatment management, 5 treatment sessions | Facility | 2023 | 51 | 228 | $243,276 | $34,552 | 14.2% |
| 77301 | High precision radiation therapy planning | Office | 2023 | 17 | 18 | $115,758 | $26,448 | 22.8% |
| G6013 | Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 11-19 mev | Office | 2023 | 34 | 130 | $91,000 | $24,411 | 26.8% |
| G6012 | Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 6-10 mev | Office | 2023 | 28 | 115 | $80,500 | $21,294 | 26.5% |
| 77427 | Radiation treatment management, 5 treatment sessions | Office | 2023 | 19 | 97 | $103,499 | $14,708 | 14.2% |
| 77338 | Design and construction of radiation treatment device for high precision radiation therapy | Office | 2023 | 17 | 26 | $68,640 | $9,682 | 14.1% |
| 77300 | Calculation of radiation therapy dose | Office | 2023 | 26 | 169 | $61,685 | $8,926 | 14.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 57 | 57 | $40,413 | $7,596 | 18.8% |
| 77336 | Continuing radiation therapy consultation per week | Office | 2023 | 26 | 105 | $36,015 | $7,251 | 20.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 84 | 107 | $39,376 | $7,079 | 18.0% |
| 77263 | Complex radiation therapy planning | Facility | 2023 | 50 | 52 | $53,144 | $6,935 | 13.0% |
| 77290 | Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved | Office | 2023 | 14 | 18 | $24,116 | $6,572 | 27.3% |
| 77334 | Design and construction of complex radiation treatment device | Facility | 2023 | 54 | 130 | $31,590 | $6,243 | 19.8% |
| G6002 | Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy | Office | 2023 | 25 | 100 | $63,700 | $6,001 | 9.4% |
| 77334 | Design and construction of complex radiation treatment device | Office | 2023 | 26 | 55 | $39,050 | $5,429 | 13.9% |
| 77301 | High precision radiation therapy planning | Facility | 2023 | 16 | 16 | $29,904 | $5,355 | 17.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 30 | 30 | $21,270 | $5,034 | 23.7% |
| 77338 | Design and construction of radiation treatment device for high precision radiation therapy | Facility | 2023 | 22 | 27 | $33,615 | $4,848 | 14.4% |
| 77300 | Calculation of radiation therapy dose | Facility | 2023 | 43 | 155 | $22,165 | $4,054 | 18.3% |
| 77263 | Complex radiation therapy planning | Office | 2023 | 28 | 30 | $30,660 | $4,008 | 13.1% |
| 77295 | 3d radiation therapy planning | Facility | 2023 | 17 | 17 | $13,566 | $3,053 | 22.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 23 | 29 | $10,672 | $2,642 | 24.8% |
About Dr. Barry Wilcox, M.D
Dr. Barry Wilcox, M.D is a Medical Oncology healthcare provider based in Dallas, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1770527624.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Barry Wilcox, M.D has received a total of $11,169 in payments from pharmaceutical and medical device companies, with $53.47 received in 2024. These payments were reported across 55 transactions from 17 companies. The most common payment nature is "Honoraria" ($5,150).
As a Medicare-enrolled provider, Wilcox has provided services to 5,134 Medicare beneficiaries, totaling 17,618 services with total Medicare billing of $2.5M. Data is available for 4 years (2020–2023), covering 159 distinct procedure/service records.
Ad
Practice Information
- Specialty Medical Oncology
- Other Specialties Radiation Oncology
- Location Dallas, TX
- Active Since 06/15/2006
- Last Updated 06/24/2015
- Taxonomy Code 207RX0202X
- Entity Type Individual
- NPI Number 1770527624
Products in Payments
- Optune (Device) $8,826
- LIBTAYO (Drug) $1,142
- Oncology (Device) $201.83
- POSLUMA (Drug) $124.99
- APTIOM (Drug) $113.34
- TAGRISSO (Drug) $100.08
- ORGOVYX (Drug) $66.88
- SUBSYS (Drug) $64.78
- IMFINZI (Drug) $45.84
- TrueBeam (Device) $36.22
- Olympus ENT Instruments (Device) $25.95
- PowerPort M.R.I. Implantable Port (Device) $25.35
- Xofigo (Drug) $23.47
- Detectnet (Drug) $23.20
- Erleada (Drug) $19.04
- SYNDROS (Drug) $18.96
- Santyl (Drug) $15.36
- IMMULITE Immunoassay Reagents/Test Kit/Clinical Utilization (Device) $11.95
- JEVTANA (Drug) $7.18
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Medical Oncology Doctors in Dallas
Dr. Moshe Levy, Md, MD
Medical Oncology — Payments: $5.0M
Medical Oncology $5.0M
Dr. Eric Nadler, Md, MD
Medical Oncology — Payments: $1.8M
Medical Oncology $1.8M
Dr. Joyce O'shaughnessy, Md, MD
Medical Oncology — Payments: $1.6M
Medical Oncology $1.6M
Dr. Thomas Hutson, Do,Pharmd, DO,PHARMD
Medical Oncology — Payments: $1.3M
Medical Oncology $1.3M
Dr. Tian Zhang, M.d, M.D
Medical Oncology — Payments: $395,066
Medical Oncology $395,066
Dr. Ashwani Agarwal, M.d, M.D
Medical Oncology — Payments: $304,262
Medical Oncology $304,262